Aurora Investment Managers’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,777
Closed -$233K 48
2022
Q4
$233K Buy
1,777
+34
+2% +$4.39K 0.23% 46
2022
Q3
$204K Hold
1,743
0.2% 49
2022
Q2
$205K Hold
1,743
0.2% 51
2022
Q1
$227K Buy
+1,743
New +$227K 0.17% 49
2021
Q2
Sell
-25,568
Closed -$3.85M 29
2021
Q1
$3.85M Sell
25,568
-3,367
-12% -$535K 4.22% 10
2020
Q4
$4.38M Sell
28,935
-2,396
-8% -$342K 4.1% 10
2020
Q3
$4.24M Buy
31,331
+254
+0.8% +$34.5K 3.84% 10
2020
Q2
$4.25M Buy
+31,077
New +$3.96M 3.44% 10

Other funds holding IBB

Aurora Investment Managers's IBB Position: Q1 2023 in Review

Aurora Investment Managers sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 1,777 shares — an estimated $233K sold.

Aurora Investment Managers first reported a position in IBB in Q2 2020 and held it in 8 quarters. The position peaked at $4.38M in Q4 2020. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • Aurora Investment Managers reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • Aurora Investment Managers sold 1,777 iShares Biotechnology ETF shares in Q1 2023, an estimated $233K.
  • Aurora Investment Managers first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 8 quarters.
  • Aurora Investment Managers's iShares Biotechnology ETF position peaked at $4.38M in Q4 2020.
  • 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Aurora Investment Managers's 13F filing for Q1 2023, filed 10 Apr 2023.